it is a small molecule rather than a biologic, yet it still activates the GLP-1R
Sleep quality improvement Sleep problems are one of the most underreported side effects of weight loss in general and GLP-1 therapy specifically
SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) cause glycosuria, meaning they dump glucose into the urine, which provides a growth medium for bacteria
If the desired research dose is 2,500mcg, the calculator indicates a draw of 0.5mL (50 units)
Its always important to consult with a healthcare provider before starting any new treatment, especially if you have pre-existing medical conditions or are taking other medications
Read more: Why are benefit leaders ideal for leading real change in the area of metabolic health